PEDIATRICS Vol. 101 No. 5 May 1998, pp. 865-869
Somatosensory Evoked Potentials in Very Preterm Infants in Relation to L-Thyroxine Supplementation
Received Jun 6, 1997; accepted Sep 9, 1997.
,
From the Departments of * Neonatology, § Clinical Epidemiology
and Biostatistics, and
Clinical Neurophysiology, Emma Children's
Hospital AMC, University of Amsterdam, Amsterdam, The Netherlands; and
the
Department of Neonatology, Wilhelmina Children's Hospital,
University of Utrecht, Utrecht, The Netherlands.
Objective. To study the effect of L-thyroxine supplementation on neurologic maturation in very preterm infants with transient hypothyroxinemia.
Design. Randomized, double-blind, placebo-controlled, L-thyroxine supplementation trial.
Setting. Level III neonatal intensive care unit.
Subjects. A total of 200 infants <30 weeks' gestational age.
Intervention. Subjects were randomly assigned to receive L-thyroxine (8 µg/kg birth weight per day) or a placebo during the first 6 weeks of life.
Methods. Median nerve somatosensory evoked potentials were recorded, measuring cortical N1 peak latency at 2 weeks of age, at term, and at 6 months (corrected) age.
Results. Cortical N1 peak latency was not decreased significantly in the L-thyroxine group compared with the placebo group throughout the study period.
Conclusion. L-Thyroxine supplementation during the first 6 weeks of life did not decrease cortical N1 peak latency in infants of <30 weeks' gestational age.
Key words: electrophysiology, evoked potentials, hypothyroidism, hypothyroxinemia, preterm infant, somatosensory, thyroxine.




